Literature DB >> 17919364

Analysis of high risk factors related to acute respiratory distress syndrome following severe thoracoabdominal injuries.

Zheng Guo-shou1, Bai Xiang-jun, Zhan Cheng-ye.   

Abstract

OBJECTIVE: To investigate the high risk factors related to acute respiratory distress syndrome(ARDS) following serious thoracoabdominal injuries.
METHODS: The clinical data of 282 patients with serious thoracoabdominal injuries were retrospectively studied. Univariate and Cox multivariate regression analysis were used to determine the risk factors related to ARDS following serious thoracoabdominal injuries.
RESULTS: The incidence of ARDS was 31.9% (90/282) in patients with serious thoracoabdominal injuries. The mortality caused by ARDS was 37.8% (34/90). The univariate analysis and multivariate analysis demonstrated that the clinical conditions such as elder age, shock, dyspnea, abnormal arterial blood gas, hemopneumothorax, pulmonary contusion, flail chest, coexisting pulmonary diseases, multiple abdominal injury and high ISS score were the independent high risk factors related to ARDS.
CONCLUSION: There are many high risk factors related to ARDS following severe thoracoabdominal injuries, which should be detected early and treated timely to decrease the incidence and mortality of A RDS.

Entities:  

Mesh:

Year:  2007        PMID: 17919364

Source DB:  PubMed          Journal:  Chin J Traumatol        ISSN: 1008-1275


  3 in total

Review 1.  Pulmonary contusion: an update on recent advances in clinical management.

Authors:  Stephen M Cohn; Joseph J Dubose
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

2.  Nationwide cohort study of independent risk factors for acute respiratory distress syndrome after trauma.

Authors:  Christopher J Tignanelli; Mark R Hemmila; Mary A M Rogers; Krishnan Raghavendran
Journal:  Trauma Surg Acute Care Open       Date:  2019-02-15

3.  Clinical study on VATS combined mechanical ventilation treatment of ARDS secondary to severe chest trauma.

Authors:  Yongjun Qi
Journal:  Exp Ther Med       Date:  2016-05-18       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.